Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,680.00
Ask: 1,810.00
Change: 0.00 (0.00%)
Spread: 130.00 (7.738%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,766.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks at one-month high on Vodafone capital return

Fri, 21st Feb 2014 11:45

- Vodafone and RBS provide a lift- Vodafone capital return lifts sentiment- IHG, Glencore Xstrata hit by downgrades- FTSE 100 at highest level in monthtechMARK 2,884.38 +0.29%FTSE 100 6,827.26 +0.21%FTSE 250 16,401.56 +0.20%UK stocks rose to levels not seen in a month on Friday as a windfall for investors at Vodafone and rumoured restructuring plans at RBS gave sentiment a lift.Markets were particularly buoyant this morning as investors speculated about which stocks could benefit from Vodafone shareholders redistributing their cash following the group's $130bn deal to sell its 45% stake in Verizon Wireless.According to analysts at Bank of America Merrill Lynch, the deal, which completes today, will be the largest capital return in corporate history and will have a drastic impact on UK trading volumes over the next few weeks.The FTSE 100 had pared gains by midday but was still trading 0.2% higher at 6,827; it has not closed above this level since January 21st. "London's main index holds above the 6,800 level for now, putting it in a position to challenge the January high of 6,867; providing the positive mood is sustained into the final week of February," said Chris Beauchamp, Market Analyst at IG. He said that the current rally "may have a little further to run".Investors largely shrugged off data this morning showing a worse-than-expected 1.5% fall in UK retail sales volumes in January. Vodafone, RBS and Glaxo provide a liftTelecoms titan Vodafone was making decent gains this morning with shareholders today set to receive a windfall from the company's sale of its holding in its US joint venture with Verizon.RBS was higher amid reports that the bank will announce plans to slash as many as 30,000 jobs, reducing its staff count to the lowest levels in more than 10 years. The speculation comes ahead of the group's 2013 results due out next week, alongside which it is expected to unveil a massive restructuring programme of its divisions.Pharmaceuticals giant GlaxoSmithKline edged higher after European regulators recommended marketing authorisation for umeclidinium, its once-daily treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.Millennium & Copthorne, the hotel firm, jumped after reporting record revenues and profits for 2013 as fourth-quarter results were boosted by the one-off sale of the bulk of the Glyndebourne development in Singapore.Sector peer InterContinental Hotels Group, however, was trading in the red after Credit Suisse lowered its recommendation from 'neutral' to 'underperform', pointing out that the shares are trading within just 4% of their all-time high at a price-to-earnings ratio of 23.Glencore Xstrata was also lower after JPMorgan Cazenove downgraded its rating on the stock from 'overweight' to 'neutral', saying that its peers have overtaken it in terms of capital returns potential.BAE Systems, which disappointed the market with its 2014 guidance yesterday, bounced slightly this morning after Societe Generale raised the stock from 'hold' to 'buy'.FTSE 100 - RisersRoyal Bank of Scotland Group (RBS) 364.10p +2.36%BAE Systems (BA.) 409.00p +2.15%ARM Holdings (ARM) 965.00p +1.90%Vodafone Group (VOD) 233.65p +1.76%Persimmon (PSN) 1,460.00p +1.60%Weir Group (WEIR) 2,355.00p +1.16%Travis Perkins (TPK) 1,984.00p +0.92%Randgold Resources Ltd. (RRS) 4,825.00p +0.81%Severn Trent (SVT) 1,812.00p +0.78%Wolseley (WOS) 3,342.00p +0.75%FTSE 100 - FallersInterContinental Hotels Group (IHG) 1,922.00p -2.68%IMI (IMI) 1,530.00p -2.24%Smiths Group (SMIN) 1,361.00p -2.09%Bunzl (BNZL) 1,469.00p -1.34%easyJet (EZJ) 1,727.00p -1.20%Prudential (PRU) 1,340.00p -1.11%International Consolidated Airlines Group SA (CDI) (IAG) 445.70p -1.07%Meggitt (MGGT) 509.00p -1.07%Glencore Xstrata (GLEN) 336.90p -1.04%ITV (ITV) 205.70p -1.01%FTSE 250 - RisersIP Group (IPO) 231.00p +7.89%Millennium & Copthorne Hotels (MLC) 598.50p +4.72%Essentra (ESNT) 882.00p +4.38%Centamin (DI) (CEY) 52.35p +3.77%Imagination Technologies Group (IMG) 187.90p +2.96%Ocado Group (OCDO) 598.00p +2.48%Big Yellow Group (BYG) 562.00p +2.46%RPC Group (RPC) 630.00p +2.36%Hunting (HTG) 838.00p +2.20%Polymetal International (POLY) 655.00p +2.18%FTSE 250 - FallersVesuvius (VSVS) 458.20p -2.86%Domino's Pizza Group (DOM) 535.00p -2.37%Evraz (EVR) 81.80p -1.56%Rank Group (RNK) 145.00p -1.56%3i Group (III) 400.50p -1.50%PZ Cussons (PZC) 358.80p -1.46%Hellermanntyton Group (HTY) 305.30p -1.45%Synthomer (SYNT) 270.20p -1.39%Cranswick (CWK) 1,288.00p -1.38%Bank of Georgia Holdings (BGEO) 2,375.00p -1.29%BC
More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.